Annual CFF
$15.46 M
+$12.23 M+378.44%
December 31, 2023
Summary
- As of February 12, 2025, IMMX annual cash flow from financing activities is $15.46 million, with the most recent change of +$12.23 million (+378.44%) on December 31, 2023.
- During the last 3 years, IMMX annual CFF has risen by +$15.46 million (+100.00%).
- IMMX annual CFF is now -17.96% below its all-time high of $18.85 million, reached on December 31, 2021.
Performance
IMMX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, IMMX quarterly cash flow from financing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, IMMX quarterly CFF has dropped by -$10.07 million (-100.00%).
- IMMX quarterly CFF is now -100.00% below its all-time high of $18.72 million, reached on December 31, 2021.
Performance
IMMX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$16.54 M
-$10.07 M-37.84%
September 30, 2024
Summary
- As of February 12, 2025, IMMX TTM cash flow from financing activities is $16.54 million, with the most recent change of -$10.07 million (-37.84%) on September 30, 2024.
- Over the past year, IMMX TTM CFF has increased by +$1.23 million (+8.07%).
- IMMX TTM CFF is now -47.16% below its all-time high of $31.29 million, reached on March 31, 2024.
Performance
IMMX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMMX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +378.4% | -100.0% | +8.1% |
| 3 y3 years | +100.0% | -100.0% | +8.1% |
| 5 y5 years | +1372.7% | -100.0% | +8.1% |
IMMX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.0% | +378.4% | -100.0% | +100.0% | -47.2% | +3682.1% |
| 5 y | 5-year | -18.0% | -100.0% | -100.0% | +100.0% | -47.2% | >+9999.0% |
| alltime | all time | -18.0% | -100.0% | -100.0% | +100.0% | -47.2% | >+9999.0% |
Immix Biopharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $16.54 M(-37.8%) |
| Jun 2024 | - | $0.00(-100.0%) | $26.60 M(-15.0%) |
| Mar 2024 | - | $15.95 M(+2618.4%) | $31.29 M(+102.4%) |
| Dec 2023 | $15.46 M(+378.4%) | $586.70 K(-94.2%) | $15.46 M(+1.1%) |
| Sep 2023 | - | $10.07 M(+114.6%) | $15.30 M(+192.3%) |
| Jun 2023 | - | $4.69 M(+3845.9%) | $5.23 M(+1097.4%) |
| Mar 2023 | - | $118.90 K(-72.0%) | $437.20 K(-86.5%) |
| Dec 2022 | $3.23 M | $424.30 K(>+9900.0%) | $3.23 M(-85.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(-100.0%) | $21.53 M(+0.1%) |
| Jun 2022 | - | -$106.00 K(-103.6%) | $21.51 M(-0.9%) |
| Mar 2022 | - | $2.91 M(-84.4%) | $21.70 M(+15.1%) |
| Dec 2021 | $18.85 M(>+9900.0%) | $18.72 M(<-9900.0%) | $18.85 M(>+9900.0%) |
| Sep 2021 | - | -$18.30 K(-122.2%) | $129.00 K(-12.4%) |
| Jun 2021 | - | $82.30 K(+26.6%) | $147.30 K(+126.6%) |
| Mar 2021 | - | $65.00 K | $65.00 K |
| Dec 2020 | $0.00(-100.0%) | - | - |
| Dec 2019 | $1.05 M | - | - |
FAQ
- What is Immix Biopharma annual cash flow from financing activities?
- What is the all time high annual CFF for Immix Biopharma?
- What is Immix Biopharma annual CFF year-on-year change?
- What is Immix Biopharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Immix Biopharma?
- What is Immix Biopharma quarterly CFF year-on-year change?
- What is Immix Biopharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Immix Biopharma?
- What is Immix Biopharma TTM CFF year-on-year change?
What is Immix Biopharma annual cash flow from financing activities?
The current annual CFF of IMMX is $15.46 M
What is the all time high annual CFF for Immix Biopharma?
Immix Biopharma all-time high annual cash flow from financing activities is $18.85 M
What is Immix Biopharma annual CFF year-on-year change?
Over the past year, IMMX annual cash flow from financing activities has changed by +$12.23 M (+378.44%)
What is Immix Biopharma quarterly cash flow from financing activities?
The current quarterly CFF of IMMX is $0.00
What is the all time high quarterly CFF for Immix Biopharma?
Immix Biopharma all-time high quarterly cash flow from financing activities is $18.72 M
What is Immix Biopharma quarterly CFF year-on-year change?
Over the past year, IMMX quarterly cash flow from financing activities has changed by -$10.07 M (-100.00%)
What is Immix Biopharma TTM cash flow from financing activities?
The current TTM CFF of IMMX is $16.54 M
What is the all time high TTM CFF for Immix Biopharma?
Immix Biopharma all-time high TTM cash flow from financing activities is $31.29 M
What is Immix Biopharma TTM CFF year-on-year change?
Over the past year, IMMX TTM cash flow from financing activities has changed by +$1.23 M (+8.07%)